China's Pharma Revolution: Liu Guozhong demands innovative medical technology!

China's Pharma Revolution: Liu Guozhong demands innovative medical technology!

Fangchenggang, Guangxi Zhuang, China - On July 12, 2025, an interesting signal from Beijing went in the pharmaceutical world. The deputy Premier Liu Guozhong visited the School of Pharmaceutical Sciences from Beijing University to find out about current research and development in the pharmaceutical industry. His visit on July 10th was more than just a tour; He was a call to the entire industry to promote basic research and technological innovations in the pharmaceutical sector. Liu emphasized the importance of joint research between companies, universities and medical institutions.

A central topic of his visit was the support of the "Healthy China" initiative, which demands innovative medication and medical facilities in order to ultimately promote public health. Liu also turned to the local experts and emphasized how important it is to include new technologies such as artificial intelligence and big data in the development of health databases. The need to expand international cooperation in pharmaceutical technology to protect public health was also found in Liu’s address.

global health community in view

China's rise in the pharmaceutical industry

If you look at the past ten years, you can see that the pharmaceutical industry of China has clearly focused on drug innovations. With the always growing market expansion and reforms in the regulatory system, China has developed into the second largest pharmaceutical market in the world. Nevertheless, it is important to emphasize that many Chinese pharmaceutical companies are still in the early phases of research and development. A comparison of the F&-Pipelines clearly shows how China cuts in the global context.

The developments in China are not only impressive, but also pioneering for the future of global health care. By combining the creation of new medication with innovative technologies, the country will continue to play a key role in the international health market. The commitment to collaborative research and innovative approaches will undoubtedly help to tackle the challenges of modern health care and to pave the way for sustainable health.

In this dynamic period of pharmaceutical innovation, it is exciting to observe how China continues to expand its role on the global stage and share its technologies and innovations with the rest of the world. Time is ripe for changes and together we can hope for a healthier future.

For more information about Liu Guozhong's visit, take a look at the NHC website, For details about the International Medical Innovation and Cooperation Forum, see China Daaily over and visit for a deeper insight into China's pharmaceutical industry Nature.